MAPT and Alzheimer disease: However, at this early stage, pathological alterations in Aβ or tau are thought to initiate disease processes including synaptic dysfunction, local damage to spines and dendrites, and vascular pathology that are observed in AD mouse models and presumably in presymptomatic humans (Ashe & Zahs, 2010).